Aranesp Associated With Increased Risk for Stroke in Patients With Diabetes and Chronic Kidney Disease

Links shared publicly online about this topic

Preview Page - http://www.medscape.com/viewarticle/711705?src=smo_onc

cli.gs — “Preview Page - http://www.medscape.com/viewarticle/711705?src=smo_oncView full resource at cli.gs

  • View Related
  • Share

Most Recently Shared on November 4, 2009 at 6:23 am By:

MedscapeOnc Medscape Oncology Oncology and Health Site

#Hematology Treating Anemia Does Not Reduce the Risk for Cardiovascular or Renal Events in Diabetics.. http://cli.gs/mWq69

3 years ago...

Anemia Drugs May Cause Deadly Blood Clots - Drugs.com MedNews

drugs.com — “New research on cancer patients adds to the controversy surrounding anemia drugs such as Procrit and Aranesp, concluding that they increase the risk of venous tView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 10, 2009 at 10:21 pm By:

drugscom Drugs.com Health Site

Anemia Drugs May Cause Deadly Blood Clots - http://bit.ly/3gcu5S

3 years ago...

Anemia Drugs May Cause Deadly Blood Clots

health.msn.com — “Anemia Drugs May Cause Deadly Blood ClotsView full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on November 10, 2009 at 9:21 pm By:

msnhealthnews msn Health News

Anemia Drugs May Cause Deadly Blood Clots http://bit.ly/2E2MQr

3 years ago...

ESA Risks, Benefits Highlighted By TREAT Study in Pre-Dialysis Patients | Research Review | NAAC National Anemia Action Council

anemia.org — “Although the benefit of erythropoiesis-stimulating agents (ESAs) has long been assumed, investigators do not know whether an increase of hemoglobin (Hb) levels through the use of ESAs will lower the risk for cardiovascular events and end-stage renal disease. The Trial to Reduce Cardiovascular Events with Aranesp therapy (TREAT) was designed to test this hypothesis in patients with type 2 diabetes, chronic kidney disease, and anemia who were not on dialysis. Unique in its comparison of an ESA to View full resource at anemia.org

  • View Related
  • Share

Most Recently Shared on November 20, 2009 at 12:58 pm By:

EndoNeuro Thomas Grobelny Doctor, Neurology, Radiologist, and Physician

Stroke News: ESA Risks, Benefits Highlighted By TREAT Study in Pre-Dialysis Pat.. http://bit.ly/3woPzj ChicagoEndovascular

3 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390